Dernières nouvelles pour Cognyte Software (NASDAQ:CGNT) Stock

Cognyte Software

Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.

Cognyte Software Ltd

Earnings

Earnings Beats

News

SHYF

Shyft Group Q1 Adj. EPS $0.07 Beats $(0.10) Estimate, Sales $204.60M Beat $198.97M Estimate

SRM Entertainment Announces It Has Recieved Six-Month Extension From Nasdaq To Regain Compliance With Minimum Bid Price Requirement

WIIM

Impinj shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 guidance above estimates.

- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months -
- Data from the fully enrolled DELIVER registrational expansion cohort is planned for late 2025 -
WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=HjhKNRK7GccpZoGiYxmFX8bQf1e2BAfI3iZOk8MvkQV2Ny2-Bl2M70_NEOCmqiKsDzhJtjn4xjlnulG3KhZth2Gq0XWyp-EXz0iDm673c_E=">Dyne Therapeutics, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that the European Commission (EC) has granted orphan drug designation for DYNE-251 for the treatment of Duchenne muscular dystrophy (DMD). DYNE-251 is being evaluated in the Phase 1/2 DELIVER global clinical trial in individuals with DMD who are amenable to exon 51 skipping. <a href="https://www.globenewswire.com/Tracker?data=BHkd4l5qn3AdVzgVo0OUPLTmtt3i9JDPiBryQnLGIMrX8sfwc3CtL9K1Or7hmVi7ac09qUu94yRcJzT2F7PAAJEQEbRBbKIdcC-hAXpp69wMxCK3emx-G1V6_TKQt9zp1_PVDetzbUvNPYVLFBKcCVtNMaZFuFbxIYbiqSn0IMQ=">Long-term clinical data</a> from the ongoing DELIVER trial of DYNE-251 that demonstrated unprecedented and sustained functional improvement at the selected registrational dose were presented in March at the 2025 Muscular Dystrophy Association (MDA) Clinical &amp; Scientific Conference. Functional assessments in the DELIVER trial include Stride Velocity 95th Centile (SV95C), an objective digital outcome that is accepted as a primary endpoint for DMD clinical trials in Europe.

EC Grants Orphan Drug Designation For Dyne Therapeutics' DYNE-251 For Treatment Of Duchenne Muscular Dystrophy

BHLB

Berkshire Hills Bancorp Q1 2025 Adj. EPS $0.60 Beats $0.53 Estimate, Sales $89.77M Miss $90.27M Estimate

Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance with its midpoint above estimates.

FirstService (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSV#NASDAQ">FSV</a>) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.83 by 10.84 percent. This is a 37.31 percent increase over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $1.25 billion which missed the analyst consensus estimate of $1.27 billion by 1.79 percent. This is a 8.03 percent increase over sales of $1.16 billion the same period last year.

Earnings Misses

FirstService Q1 Adj. EPS $0.92 Beats $0.83 Estimate, Sales $1.25B Miss $1.27B Estimate

STBA

S&T Bancorp Q1 EPS $0.87 Beats $0.75 Estimate, Sales $93.75M Miss $96.40M Estimate

TSCO

Tractor Supply shares are trading lower after the company reported mixed Q1 financial results and lowered its FY25 EPS guidance with its midpoint below estimates.

Canaccord Genuity analyst Richard Davis maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy and raises the price target from $900 to $1075.

Price Target

Analyst Ratings

Canaccord Genuity Maintains Buy on ServiceNow, Raises Price Target to $1075

STMicroelectronics shares are trading higher after the company reported better-than-expected Q1 financial results and issued its Q2 revenue guidance with its midpoint above estimates.

West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTBA#NASDAQ">WTBA</a>) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.38 by 21.05 percent. This is a 31.43 percent increase over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $23.10 million which beat the analyst consensus estimate of $21.61 million by 6.89 percent. This is a 21.26 percent increase over sales of $19.05 million the same period last year.

WTBA

West Bancorp Q1 EPS $0.46 Beats $0.38 Estimate, Sales $23.10M Beat $21.61M Estimate

TransUnion shares are trading higher after  the company reported better-than-expected Q1 financial results and raised its FY25 EPS guidance and sales guidance.

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) saw a drop in new car sales in Europe even as overall vehicle sales in the region increased.
What Happened: Data released by the European Automobile Manufacturers Association (ACEA) showed that Tesla sales dropped by 28% in the region as Tesla's market share has dropped to 2% from 2.9% around the same time last year, Reuters reported on Thursday.
Sales for new BEV or Battery Electric Vehicles rose by 17.1% in the region as Electrified vehicles like BEVs, Hybrid Electric Vehicles, and Plug-In Hybrids accounted for over 59.2% of new vehicle registrations, the report said.
Elsewhere, registrations for Volkswagen AG were up 10.3% while Renault experienced a 13% surge. However, Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) experienced a 5.9% decline in sales. According to the data, Hybrid electric vehicles continue to dominate the region with over 35.5% of new registrations.&nbsp;
Why It Matters: News of the decline in sales figures comes in as Tesla experienced a 71% plunge in YoY profits. Amid this, the company said it will be releasing cheaper models at the Q1 2025 earnings call, but that could prove to do more harm than good, <a href="https://www.benzinga.com/markets/25/04/44971532/teslas-new-cheaper-cars-might-not-be-the-game-changer-investors-hoped-for-warns-gary-black-heres-why-he-thinks-they-could-hurt-more-than-help">according to experts</a>.
Tesla also quietly<a href="https://www.benzinga.com/markets/25/04/44919745/cybertruck-gets-a-down-to-earth-redesign-as-tesla-shifts-to-traditional-pickup-marketing-amid-poor-sales"> changed the marketing strategy</a> for its Cybertruck, positioning it as a lifestyle product capable of hauling construction materials, trailers, and tackling rugged terrain. The company also unveiled <a href="https://www.benzinga.com/markets/equities/25/04/44755221/tesla-unveils-new-cybertruck-long-range-trim-with-a-362-mile-range-and-reduced-features">a cheaper version </a>of the Cybertruck recently.&nbsp;
CEO Elon Musk also <a href="https://www.benzinga.com/25/04/44940401/elon-musk-says-hell-only-spend-day-or-two-per-week-on-government-matters-to-ensure-fraud-does-not-come-roaring-back-ceos-focus-to-shift-to-tesla-beginning-may">reiterated his commitment</a> to the company at the earnings call on Tuesday, which inspired confidence among investors as Tesla stock experienced a 5% surge in after-hours trading.
Despite the decline in sales, experts are confident that Tesla will continue to grow, as <a href="https://www.benzinga.com/25/04/44971783/piper-sandler-puts-400-price-target-on-tesla-it-appears-our-best-case-scenario-has-materialized">investment bank Piper Sandler</a> raised the price target on Tesla stock to $400, while Dan Ives raised it to $350.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="190" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24065756/Screenshot-2025-04-24-at-11.09.19-AM-1-1024x190.jpg" alt="" class="wp-image-886237" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24065756/Screenshot-2025-04-24-at-11.09.19-AM-1-1024x190.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24065756/Screenshot-2025-04-24-at-11.09.19-AM-1-300x56.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24065756/Screenshot-2025-04-24-at-11.09.19-AM-1-768x143.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24065756/Screenshot-2025-04-24-at-11.09.19-AM-1-1536x285.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24065756/Screenshot-2025-04-24-at-11.09.19-AM-1.jpg 1744w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
According to Benzinga Edge stock Rankings, Tesla scores well across all metrics except Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44943387/elon-musk-shares-fsd-update-at-tesla-earnings-call-10-to-20-model-ys-will-offer-paid-robotaxi-rides-in-june">Elon Musk Shares FSD Update At Tesla Earnings Call: &#8217;10 To 20&#8242; Model Ys Will Offer Paid Robotaxi Rides In June</a></li>
</ul>
Image Via Shutterstock

Eurozone

Markets

Tech

General

STLA

TSLA

Tesla Loses Ground In Europe As Competitors Gain, Market Share Falls To 2% Amid 28% Sales Decline: ACEA DATA

Nokia shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results. Also, the company announced that tariffs may cut its Q2 comparable operating profit and there are no assumptions being made for H2 due to ongoing uncertainty.

TCBK

TriCo Q1 EPS $0.80 Beats $0.78 Estimate, Sales $98.61M Miss $99.59M Estimate

Guidance

American Airline Says Co Withdrawing FY25 Guidance At This Time

Raymond James analyst Michael Rose downgrades Amerant Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTB#NYSE">AMTB</a>) from Outperform to Market Perform.

Downgrades

AMTB

Raymond James Downgrades Amerant Bancorp to Market Perform

TrueBlue's PeopleScout Launches Global Outthink Index To Elevate Employer Brand Performance

Raymond James analyst James Rollyson downgrades Weatherford International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) from Strong Buy to Outperform and lowers the price target from $73 to $69.

WFRD

Raymond James Downgrades Weatherford International to Outperform, Lowers Price Target to $69

Press Releases

Cognyte Elects Two New Board Members to Strengthen Expertise and Drive Growth

EMEA National Security Agency Invests Over $5M in Cognyte Portfolio to Enhance Public Safety, Highlighting Trust in Advanced Solutions

Cognyte to Host Analyst & Investor Day

Cognyte Integrates with Microsoft Azure to Enhance AI Data Analytics Solution

Cognyte Appoints Distinguished Innovator Ronny Lempel as Chief Technology Officer to Guide AI-Focused Research

Cognyte to Announce Fourth Quarter and Full Year FYE25 Financial Results on April 2, 2025

Cognyte Secures a $20+ Million Annual Three-Year Agreement With a National Security Agency

Cognyte Reports Fourth Quarter and Fiscal Year Ended January 31, 2025 Financial Results

Cognyte Announces Agenda for Virtual Analyst and Investor Day on April 8

Cognyte 2025 Threat Landscape Report Reveals Global Trends in Cyberattacks, Ransomware and Stolen Credentials

Comments

Cognyte Software

Actualités

Dernières nouvelles pour Cognyte Software (NASDAQ:CGNT) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL